{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:36:06Z","timestamp":1787589366522,"version":"build-2736575974"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006292","name":"Infectious Diseases Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N91019D00024"],"award-info":[{"award-number":["75N91019D00024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This article provides a focused update to the clinical practice guideline on the treatment and management of patients with COVID-19, developed by the Infectious Diseases Society of America. The guideline panel presents a new recommendation on the use of baricitinib vs. tocilizumab in hospitalized adults with severe or critical COVID-19. The panel has previously issued recommendations on baricitinib vs. no baricitinib and tocilizumab vs. no tocilizumab, but this new recommendation compares baricitinib to tocilizumab when the decision has been made to give one or the other. The new recommendation does not address combinations of multiple immunomodulatory agents (ie, baricitinib, tocilizumab, abatacept, infliximab). The recommendation is based on evidence derived from a systematic literature review and adheres to a standardized methodology for rating the certainty of evidence and strength of recommendation according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach.<\/jats:p>","DOI":"10.1093\/cid\/ciaf681","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:43:15Z","timestamp":1771591395000},"page":"i18-i23","source":"Crossref","is-referenced-by-count":0,"title":["2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab"],"prefix":"10.1093","volume":"82","author":[{"given":"Nandita","family":"Nadig","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine , Chicago, Illinois ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5008-3128","authenticated-orcid":false,"given":"Adarsh","family":"Bhimraj","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Houston Methodist Hospital , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Cawcutt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Nebraska Medical Center , Omaha, Nebraska ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0204-8708","authenticated-orcid":false,"given":"Kathleen","family":"Chiotos","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia\/University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L","family":"Dzierba","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York University Grossman School of Medicine , New York City, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Y","family":"Kim","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Medicine, Massachusetts General Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9684-7593","authenticated-orcid":false,"given":"Greg S","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C","family":"Pearson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Brigham and Women's Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Hirsch","family":"Shumaker","sequence":"additional","affiliation":[{"name":"Department of Medicine, Case Western Reserve University, School of Medicine , Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Medicine, VA Northeast Ohio Healthcare System , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R","family":"Baden","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Medicine, Brigham and Women's Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9794-0389","authenticated-orcid":false,"given":"Roger","family":"Bedimo","sequence":"additional","affiliation":[{"name":"Department of Medicine, UT Southwestern\/VA North Texas Health Care System , Dallas, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Chi-Chung","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Queen Mary Hospital, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Pokfulam, Hong Kong Special Administrative Region ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4865-4348","authenticated-orcid":false,"given":"Kara W","family":"Chew","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-7331","authenticated-orcid":false,"given":"Eric S","family":"Daar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harbor-UCLA Medical Center , Torrance, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V","family":"Glidden","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, UCSF , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica J","family":"Hardy","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Obstetrics and Gynecology, Brown University , Providence, Rhode Island ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Colorado School of Medicine , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"MacBrayne","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children's Hospital Colorado , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari M","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Antimicrobial Stewardship Program and Division of Infectious Diseases, Boston Children's Hospital , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Pediatrics, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5043-4569","authenticated-orcid":false,"given":"Laura","family":"Riley","sequence":"additional","affiliation":[{"name":"New York-Presbyterian Hospital\/Weill Cornell Medical Center , New York City, New York ,","place":["USA"]},{"name":"Department of Obstetrics and Gynecology, Weill Cornell Medicine , New York City, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Shafer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University , Palo Alto, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-7786","authenticated-orcid":false,"given":"Shmuel","family":"Shoham","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-7942","authenticated-orcid":false,"given":"Pablo","family":"Tebas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis C","family":"Tien","sequence":"additional","affiliation":[{"name":"Department of Medicine, UCSF\/VA San Francisco Health Care System , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6372-5274","authenticated-orcid":false,"given":"Zachary","family":"Willis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9912-3646","authenticated-orcid":false,"given":"Joshua","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Loveless","sequence":"additional","affiliation":[{"name":"Clinical Affairs and Practice Guidelines, Infectious Diseases Society of America , Arlington, Virginia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yngve","family":"Falck-Ytter","sequence":"additional","affiliation":[{"name":"Department of Medicine, Case Western Reserve University, School of Medicine , Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Medicine, VA Northeast Ohio Healthcare System , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Case Western Reserve University, School of Medicine , Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh T","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Medicine, Massachusetts General Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2026082412161369600_ciaf681-B1","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with COVID-19","volume":"384","author":"REMAP-CAP Investigators","year":"2021","journal-title":"N Engl J Med"},{"key":"2026082412161369600_ciaf681-B2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciaa272","article-title":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China","volume":"71","author":"Wang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026082412161369600_ciaf681-B3","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/JVI.01792-08","article-title":"Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells","volume":"83","author":"Yoshikawa","year":"2009","journal-title":"J Virol"},{"key":"2026082412161369600_ciaf681-B4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendation","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2026082412161369600_ciaf681-B5","author":"Infectious Diseases Society of America"},{"key":"2026082412161369600_ciaf681-B6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/phar.2867","article-title":"Baricitinib versus tocilizumab in critically ill COVID-19 patients: a retrospective cohort study","volume":"44","author":"Conroy","year":"2024","journal-title":"Pharmacotherapy"},{"key":"2026082412161369600_ciaf681-B7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cmi.2022.10.015","article-title":"Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial","volume":"29","author":"Karampitsakos","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2026082412161369600_ciaf681-B8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s15010-022-01915-7","article-title":"Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort","volume":"51","author":"Karolyi","year":"2023","journal-title":"Infection"},{"key":"2026082412161369600_ciaf681-B9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/medicina58040513","article-title":"Comparative efficacy of tocilizumab and baricitinib administration in COVID-19 treatment: a retrospective cohort study","volume":"58","author":"Kojima","year":"2022","journal-title":"Medicina"},{"key":"2026082412161369600_ciaf681-B10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijid.2022.10.037","article-title":"Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study","volume":"125","author":"Lakatos","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2026082412161369600_ciaf681-B11","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/CCM.0000000000006444","article-title":"Comparative effectiveness of baricitinib versus tocilizumab in hospitalized patients with COVID-19: a retrospective cohort study of the national COVID collaborative","volume":"53","author":"Patanwala","year":"2025","journal-title":"Crit Care Med"},{"key":"2026082412161369600_ciaf681-B12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/CCM.0000000000005756","article-title":"Outcomes and adverse effects of baricitinib versus tocilizumab in the management of severe COVID-19","volume":"51","author":"Peterson","year":"2023","journal-title":"Crit Care Med"},{"key":"2026082412161369600_ciaf681-B13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1177\/10600280221133376","article-title":"Baricitinib versus tocilizumab for the treatment of moderate to severe COVID-19","volume":"57","author":"Reid","year":"2023","journal-title":"Ann Pharmacother"},{"key":"2026082412161369600_ciaf681-B14","first-page":"e0702","article-title":"Tocilizumab versus baricitinib in patients hospitalized with COVID-19 pneumonia and hypoxemia: a multicenter retrospective cohort study","volume":"4","author":"Roddy","year":"2022","journal-title":"Crit Care Explor"},{"key":"2026082412161369600_ciaf681-B15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.reuma.2020.10.009","article-title":"Experience with the use of baricitinib and tocilizumab monotherapy or combined, in patients with interstitial pneumonia secondary to coronavirus COVID19: a real-world study","volume":"18","author":"Rosas","year":"2022","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"2026082412161369600_ciaf681-B16","doi-asserted-by":"crossref","first-page":"ofad426","DOI":"10.1093\/ofid\/ofad426","article-title":"Comparison of tocilizumab vs baricitinib in clinical outcomes among hospitalized patients with COVID-19: experience from a public hospital system in New York city","volume":"10","author":"Sunny","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026082412161369600_ciaf681-B17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/17476348.2025.2473486","article-title":"Comparison of effectiveness and safety between baricitinib and tocilizumab in severe COVID-19: a retrospective study","volume":"19","author":"Tomos","year":"2025","journal-title":"Expert Rev Respir Med"},{"key":"2026082412161369600_ciaf681-B18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/08971900231158931","article-title":"Tocilizumab versus baricitinib for the treatment of COVID-19 in patients with obesity","volume":"37","author":"Troyer","year":"2024","journal-title":"J Pharm Pract"},{"key":"2026082412161369600_ciaf681-B19","author":"Baricitinib package insert"},{"key":"2026082412161369600_ciaf681-B20","author":"Tocilizumab package insert"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf681\/67713812\/ciaf681.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_3\/i18\/67713812\/ciaf681.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_3\/i18\/67713812\/ciaf681.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:16:21Z","timestamp":1787588181000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/Supplement_3\/i18\/8571316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":20,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,8,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf681","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,15]]},"published":{"date-parts":[[2026,4,1]]}}}